Visit Provider
  • Flat-rate pricing
  • Prescription included · Online questionnaire, no video call · Dose adjustment supported
  • Multiple pharmacy options · Third-party tested
  • Free shipping · Supplies included · Discreet packaging
  • Tirzepatide, Semaglutide · Zepbound, Wegovy, Foundayo
  • Available in all 50 states
  • Pricing varies by pharmacy
  • Auto-renewing plans · Cancellation terms apply
  • Other fees may apply
  • Mixed additive-free options

Provider Plans

12-Month Injectable Program
TirzepatideBundleShips Every 4-Weeks
$239/avg
PharmacyStrive (503A)
Promise (503A)
AdditivesNone or Cyanocobalamin (B12) or Glycine
PreservativeBenzyl Alcohol
BUD (Shelf Life)90 Days
BillingMonthly
Commitment12-Month Agreement
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$239.0010mg$239$23.90/mg
5.0mg/wk20mg/mo$239.0020mg$239$11.95/mg
7.5mg/wk30mg/mo$239.0030mg$239$7.97/mg
10.0mg/wk40mg/mo$239.0040mg$239$5.97/mg
12.5mg/wk50mg/mo$239.0050mg$239$4.78/mg
15.0mg/wk60mg/mo$239.0060mg$239$3.98/mg
The fee may be paid in full or in installments selected at checkout. After the term, it renews at the standard monthly rate.
6-Month Injectable Program
TirzepatideBundleShips Every 4-Weeks
$269/avg
PharmacyStrive (503A)
Promise (503A)
AdditivesNone or Cyanocobalamin (B12) or Glycine
PreservativeBenzyl Alcohol
BUD (Shelf Life)90 Days
BillingMonthly
Commitment6-Month Agreement
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$269.0010mg$269$26.90/mg
5.0mg/wk20mg/mo$269.0020mg$269$13.45/mg
7.5mg/wk30mg/mo$269.0030mg$269$8.97/mg
10.0mg/wk40mg/mo$269.0040mg$269$6.72/mg
12.5mg/wk50mg/mo$269.0050mg$269$5.38/mg
15.0mg/wk60mg/mo$269.0060mg$269$4.48/mg
The fee may be paid in full or in installments selected at checkout. After the term, it renews at the standard monthly rate.
1-Month Injectable Program
TirzepatideBundleShips Every 4-Weeks
$299/avg
PharmacyStrive (503A)
Promise (503A)
AdditivesNone or Cyanocobalamin (B12) or Glycine
PreservativeBenzyl Alcohol
BUD (Shelf Life)90 Days
BillingMonthly
Commitment2-Month Agreement
Other FeesNo Extra Fees
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$299.0010mg$299$29.90/mg
5.0mg/wk20mg/mo$299.0020mg$299$14.95/mg
7.5mg/wk30mg/mo$299.0030mg$299$9.97/mg
10.0mg/wk40mg/mo$299.0040mg$299$7.47/mg
12.5mg/wk50mg/mo$299.0050mg$299$5.98/mg
15.0mg/wk60mg/mo$299.0060mg$299$4.98/mg
The product card says 1 Month. The Terms impose a two-month minimum on medication programs.
Zepbound Vial
TirzepatideBundleShips Every 4-WeeksBrand
$349/avg
PharmacyEli Lilly
AdditivesNone
PreservativeNot Disclosed
BUD (Shelf Life)24 Months
BillingMonthly
Commitment2-Month Agreement
Other Fees$125 Consultation
Auto-RenewsYes
DoseYour SupplyYour PriceYour SupplyAvg/moYour Value
2.5mg/wk10mg/mo$349.0010mg$349$34.90/mg
5.0mg/wk20mg/mo$349.0020mg$349$17.45/mg
7.5mg/wk30mg/mo$349.0030mg$349$11.63/mg
10.0mg/wk40mg/mo$349.0040mg$349$8.72/mg
12.5mg/wk50mg/mo$349.0050mg$349$6.98/mg
15.0mg/wk60mg/mo$349.0060mg$349$5.82/mg
Consultation fee not included
Cash medication pricing is stated as $349 to $499 per month for new patients. No per-dose breakdown is published.

Provider Details

Fully Online Care

In-House RxDose Adjustments By Appointment
Prescription IncludedYes
Telehealth IncludedYes
Online-Only OptionYes
Skip LabsNot Disclosed

Accepts Insurance

CreditAffirmAfterpayKlarna
Insurance AcceptedYes
HSA/FSA AcceptedYes
Financing AvailableYes

LegitScript Certified

Trustpilot 4.7150,000+ Patients
LegitScript CertifiedYes
HIPAA CompliantYes
Mobile AppNot Disclosed

Free Shipping

Supplies IncludedCold-Packed
Free ShippingYes
Expedited ShippingNo
Discreet PackagingYes

Tirz + Sema · 503A

Formats: Injection · Oral SublingualBrands: Foundayo · Wegovy Pen Cash · +4
Offers TirzepatideYes
Offers SemaglutideYes
Offers BrandYes
Other TreatmentsYes

Provider Notes

Compliance

The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.